| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,300 | 22,786 | 23,277 | 34,881 | | Cost of Revenue | 11,839 | 12,584 | 12,298 | 15,661 | | | Gross Profit | 11,461 | 10,202 | 10,979 | 19,220 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,878 | 2,763 | 2,857 | 3,328 | | Non Recurring | 324 | 1,507 | (96) | (294) | | Others | 9,452 | 10,364 | 11,768 | 27,029 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (981) | (4,432) | (3,550) | (10,843) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 398 | 28 | 10 | 27 | | Earnings Before Interest And Taxes | (974) | (4,404) | (3,540) | (11,080) | | Interest Expense | 2,162 | 1,569 | 1,566 | 1,782 | | Income Before Tax | (3,136) | (5,973) | (5,106) | (12,862) | | Income Tax Expense | (1,165) | (1,987) | (1,623) | (4,581) | | Minority Interest | (344) | (168) | (15) | (264) | | | | Net Income From Continuing Ops | (2,315) | (4,154) | (3,498) | (8,281) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,315) | (4,154) | (3,498) | (8,281) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,315) | ($4,154) | ($3,498) | ($8,281) |
|
0.10% Nasdaq 
Income Statement
